BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36456101)

  • 1. Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses.
    Joachims ML; Khatri B; Li C; Tessneer KL; Ice JA; Stolarczyk AM; Means N; Grundahl KM; Glenn SB; Kelly JA; Lewis DM; Radfar L; Stone DU; Guthridge JM; James JA; Scofield RH; Wiley GB; Wren JD; Gaffney PM; Montgomery CG; Sivils KL; Rasmussen A; Farris AD; Adrianto I; Lessard CJ
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36456101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNAs in Sjögren's Disease.
    Pastva O; Klein K
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren's Patients Reveals Interferon Signature.
    Maleki-Fischbach M; Anderson K; Fernández Pérez ER
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.
    Shi H; Cao N; Pu Y; Xie L; Zheng L; Yu C
    Arthritis Res Ther; 2016 May; 18(1):109. PubMed ID: 27188286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Hepatitis D Virus in Minor Salivary Gland of Sjögren's Disease.
    Hesterman MC; Furrer SV; Fallon BS; Weller ML
    J Dent Res; 2023 Oct; 102(11):1272-1279. PubMed ID: 37575047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood gene expression profiling in Sjögren's syndrome.
    Emamian ES; Leon JM; Lessard CJ; Grandits M; Baechler EC; Gaffney PM; Segal B; Rhodus NL; Moser KL
    Genes Immun; 2009 Jun; 10(4):285-96. PubMed ID: 19404300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vimentin antibodies are associated with higher severity of Sjögren's disease.
    Bagavant H; Araszkiewicz AM; Rasmussen A; Pezant N; Montgomery C; Scofield RH; Farris D; Lessard CJ; Deshmukh US
    Clin Immunol; 2023 Feb; 247():109243. PubMed ID: 36702181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's Disease.
    Gupta S; Yamada E; Nakamura H; Perez P; Pranzatelli TJF; Dominick K; Jang SI; Abed M; Martin D; Burbelo P; Zheng C; French B; Alevizos I; Khavandgar Z; Beach M; Pelayo E; Walitt B; Hasni S; Kaplan MJ; Tandon M; Teresa Magone M; Kleiner DE; Chiorini JA; Baer AN; Warner BM
    medRxiv; 2023 Aug; ():. PubMed ID: 37662351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.
    McCoy SS; Parker M; Gurevic I; Das R; Pennati A; Galipeau J
    Rheumatology (Oxford); 2022 Oct; 61(10):4207-4218. PubMed ID: 35218354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren's disease and predict abnormal labial salivary gland pathology.
    Parker M; Zheng Z; Lasarev M; Alexandridis RA; Newton MA; Shelef MA; McCoy SS
    medRxiv; 2023 Aug; ():. PubMed ID: 37693588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning for the Identification of a Common Signature for Anti-SSA/Ro 60 Antibody Expression Across Autoimmune Diseases.
    Foulquier N; Le Dantec C; Bettacchioli E; Jamin C; Alarcón-Riquelme ME; Pers JO
    Arthritis Rheumatol; 2022 Oct; 74(10):1706-1719. PubMed ID: 35635731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential long non-coding RNA expression profile and function analysis in primary Sjogren's syndrome.
    Chen X; Cheng Q; Du Y; Liu L; Wu H
    BMC Immunol; 2021 Jul; 22(1):47. PubMed ID: 34284720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells and IFN-γ-producing Th1 cells play a critical role in the pathogenesis of Sjögren's Syndrome.
    Wang YH; Li W; McDermott M; Son GY; Maiti G; Zhou F; Tao A; Raphael D; Moreira AL; Shen B; Vaeth M; Nadorp B; Chakravarti S; Lacruz RS; Feske S
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells.
    Katsiougiannis S; Tenta R; Skopouli FN
    Clin Exp Immunol; 2015 Aug; 181(2):244-52. PubMed ID: 25845745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
    Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
    J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study.
    McCoy SS; Hetzel S; VanWormer JJ; Bartels CM
    Clin Rheumatol; 2022 Oct; 41(10):3065-3074. PubMed ID: 35701626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.